Dublin, May 11, 2026 (GLOBE NEWSWIRE)-- The "Prefilled Syringes Market by Type, Material, Design, Application, & Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...

Dublin, April 08, 2026 (GLOBE NEWSWIRE)-- The "Pharmaceutical Glass Packaging Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Pharmaceutical Glass ...

The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...

Administering medication in an acute setting can come with significant waste. In a recent study, researchers discovered that the cost associated with wasting morphine, fentanyl and hydromorphone was ...

Azmiro TM (testosterone cypionate) is now available in a prefilled syringe formulation for testosterone replacement therapy in males for conditions associated with a deficiency or absence of ...

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

(MENAFN- GlobeNewsWire - Nasdaq) The global prefilled syringes market is forecasted to grow from USD 8.65 billion in 2026 to USD 14.53 billion by 2031, at a CAGR of 10.9%. Key growth drivers include ...